Back to Search
Start Over
Update on advances in molecular PET in urological oncology
- Source :
- Japanese Journal of Radiology. 34:470-485
- Publication Year :
- 2016
- Publisher :
- Springer Science and Business Media LLC, 2016.
-
Abstract
- Integrated positron emission tomography/computed tomography (PET/CT) with 2-[(18)F]fluoro-2-deoxy-D-glucose ((18)F-FDG) has emerged as a powerful tool for the combined metabolic and anatomic evaluation of many cancers. In urological oncology, however, the use of (18)F-FDG has been limited by a generally low tumor uptake, and physiological excretion of FDG through the urinary system. (18)F-FDG PET/CT is useful when applied to specific indications in selected patients with urological malignancy. New radiotracers and positron emission tomography/magnetic resonance imaging (PET/MRI) are expected to further improve the performance of PET in uro-oncology.
- Subjects :
- Male
Urologic Neoplasms
medicine.medical_specialty
medicine.medical_treatment
Malignancy
Multimodal Imaging
Article
030218 nuclear medicine & medical imaging
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Fluorodeoxyglucose F18
Positron Emission Tomography Computed Tomography
Humans
Medicine
Radiology, Nuclear Medicine and imaging
Urinary Tract
Bladder cancer
medicine.diagnostic_test
business.industry
Magnetic resonance imaging
medicine.disease
Magnetic Resonance Imaging
Radiation therapy
Positron emission tomography
Positron-Emission Tomography
030220 oncology & carcinogenesis
Female
Radiology
Radiopharmaceuticals
business
Nuclear medicine
Kidney cancer
Preclinical imaging
Subjects
Details
- ISSN :
- 1867108X and 18671071
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Japanese Journal of Radiology
- Accession number :
- edsair.doi.dedup.....7b683967a344b2b6149765d5ca2f6898